Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2012 Oct;67(4):760-8.
doi: 10.1016/j.jaad.2011.12.021. Epub 2012 Jan 30.

Pruritus in cutaneous T-cell lymphoma: a review

Kristen Ahern  1 , Elaine S Gilmore, Brian Poligone
Affiliations
Review

Pruritus in cutaneous T-cell lymphoma: a review

Kristen Ahern et al. J Am Acad Dermatol. 2012 Oct.

Abstract

Background: Pruritus can be a distressing and even debilitating symptom for patients with cutaneous T-cell lymphoma (CTCL). To date, few studies have evaluated the pathophysiology of this symptom. Because of this, therapy for pruritus in CTCL has mainly relied on those therapies that target and treat the lymphoma. For patients living with CTCL that relapses or becomes refractory to treatment, and who continue to experience severe itch, this lymphoma-targeted treatment may not be enough to combat their pruritus. Therefore, other itch-targeted therapies are needed for use in this disease.

Objective: We sought to evaluate the current evidence regarding the mechanism of action and treatments for pruritus associated with CTCL.

Methods: An explicit and thorough search was restricted to all peer-reviewed literature available through MEDLINE (1950 to September 2011) and PubMed. Search terms used were "pruritus," "cutaneous T-cell lymphoma," "CTCL," "mycosis fungoides," "MF," and "Sézary syndrome." All studies that involved pruritus in CTCL, mycosis fungoides, or Sézary syndrome were evaluated by all 3 authors.

Results: The current literature helps to identify therapies and possible mechanisms for treating patients with CTCL-associated pruritus.

Limitation: Most studies were preclinical. Only studies involving mechanisms of action or treatment were included.

Conclusion: A guideline is necessary to assist in the treatment of pruritus in CTCL and additional studies are necessary to uncover the exact mechanism or mechanisms of action.

PubMed Disclaimer

References

    1. Rothman S. Physiology of Itching. Physiological Reviews. 1941 Apr 1;21(2):357–81. 1941.
    1. Dereure O, Guilhou JJ. Invisible mycosis fungoides: a new case. J Am Acad Dermatol. 2001 Aug;45(2):318–9. - PubMed
    1. Pujol RM, Gallardo F, Llistosella E, Blanco A, Bernado L, Bordes R, Nomdedeu JF, Servitje O. Invisible mycosis fungoides: a diagnostic challenge. J Am Acad Dermatol. 2002 Aug;47(2 Suppl):S168–71. - PubMed
    1. Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, Ralfkiaer E, Chimenti S, Diaz-Perez JL, Duncan LM, Grange F, Harris NL, Kempf W, Kerl H, Kurrer M, Knobler R, Pimpinelli N, Sander C, Santucci M, Sterry W, Vermeer MH, Wechsler J, Whittaker S, Meijer CJ. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005 May 15;105(10):3768–85. - PubMed
    1. Winkelmann RK, Caro WA. Current problems in mycosis fungoides and Sezary syndrome. Annu Rev Med. 1977;28:251–69. - PubMed

Publication types